TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET 40
1.4 LIMITATIONS 41
1.5 MARKETS COVERED 42
2 MARKET SEGMENTATION 46
2.1 MARKETS COVERED 46
2.2 GEOGRAPHICAL SCOPE 47
2.3 YEARS CONSIDERED FOR THE STUDY 48
2.4 CURRENCY AND PRICING 48
2.5 DBMR TRIPOD DATA VALIDATION MODEL 49
2.6 GRADE LIFE LINE CURVE 52
2.7 MULTIVARIATE MODELING 53
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.9 DBMR MARKET POSITION GRID 56
2.10 MARKET END-USER COVERAGE GRID 57
2.11 DBMR MARKET CHALLENGE MATRIX 58
2.12 DBMR VENDOR SHARE ANALYSIS 59
2.13 IMPORT-EXPORT DATA 60
2.14 SECONDARY SOURCES 61
2.15 ASSUMPTIONS 62
3 EXECUTIVE SUMMARY 63
4 PREMIUM INSIGHTS 65
4.1 PESTLE ANALYSIS 66
4.1.1 POLITICAL FACTORS 66
4.1.2 ECONOMIC FACTORS 66
4.1.3 SOCIAL FACTORS 67
4.1.4 TECHNOLOGICAL FACTORS 67
4.1.5 LEGAL FACTORS 67
4.1.6 ENVIRONMENTAL FACTORS 67
4.2 PORTERS FIVE FORCES: 68
4.2.1 THREAT OF NEW ENTRANTS: 68
4.2.2 THREAT OF SUBSTITUTES: 68
4.2.3 CUSTOMER BARGAINING POWER: 69
4.2.4 SUPPLIER BARGAINING POWER: 69
4.2.5 INTERNAL COMPETITION (RIVALRY): 69
4.3 CLIMATE CHANGE SCENARIO 70
4.3.1 ENVIRONMENTAL CONCERNS 70
4.3.2 INDUSTRY RESPONSE 70
4.3.3 GOVERNMENTS ROLE 70
4.3.4 ANALYST RECOMMENDATION 70
4.4 LIST OF KEY PATENTS LAUNCHED 71
4.5 SUPPLY CHAIN ANALYSIS 72
4.6 VENDOR SELECTION CRITERIA 74
5 MARKET OVERVIEW 75
5.1 DRIVERS 77
5.1.1 APPLICATION AS EXCIPIENT IN PHARMACEUTICAL PRODUCTS 77
5.1.2 GROWTH IN THE FAST-MOVING CONSUMER GOODS INDUSTRY 77
5.1.3 INCREASE IN DEMAND FROM END-USER INDUSTRIES 78
5.2 RESTRAINTS 78
5.2.1 VOLATILITY IN RAW MATERIAL PRICES 78
5.2.2 USAGE OF HARMFUL CHEMICALS IN POLYVINYLPYRROLIDONE PRODUCTION 79
5.3 OPPORTUNITIES 79
5.3.1 GROWTH IN RESEARCH AND DEVELOPMENT ACTIVITIES 79
5.3.2 SUPPORTIVE CHEMICAL INDUSTRY OUTLOOK IN EMERGING ECONOMIES 80
5.4 CHALLENGES 80
5.4.1 CREDIBLE THREAT OF OTHER SUBSTITUTES 80
6 MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET, BY GRADE 81
6.1 OVERVIEW 82
6.2 K30 84
6.3 K90 85
6.4 K12 86
6.5 K25 87
6.6 K17 88
6.7 K60 89
6.8 K120 90
6.9 CROSPOVIDONE 91
6.10 COPOVIDONE 92
6.11 XL-10 93
6.12 ULTRA-10 94
6.13 KOLLIDON SR 95
6.14 KOLLIDON CL 96
6.15 OTHERS 97
7 MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET, BY TYPE 99
7.1 OVERVIEW 100
7.2 MEDIUM MOLECULAR WEIGHT 101
7.3 HIGH MOLECULAR WEIGHT 101
7.4 LOW MOLECULAR WEIGHT 102
8 MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET, BY FORM 104
8.1 OVERVIEW 105
8.2 POWDER 106
8.3 LIQUID 106
9 MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET, BY APPLICATION 108
9.1 OVERVIEW 109
9.2 PHARMACEUTICAL 110
9.2.1 TABLETS 111
9.2.2 LIQUID SUSPENSIONS/OINTMENT 111
9.2.3 INJECTIONS 111
9.2.4 OTHERS 112
9.3 COSMETICS 112
9.3.1 HAIR FIXATIVE POLYMERS 113
9.3.2 SKIN CARE 113
9.3.3 ORAL CARE 113
9.3.4 PERFUMES 113
9.4 SOLVENTS 113
9.4.1 INKS 114
9.4.2 PAINTS & COATINGS 114
9.4.3 POLISHING AGENTS 114
9.5 ELECTRICAL & ELECTRONICS 115
9.5.1 BATTERIES 116
9.5.2 PCBS 116
9.5.3 OTHERS 116
9.5.3.1 SCREENS 116
9.5.3.2 CMP 116
9.6 ADHESIVES 116
9.6.1 HOT MELT ADHESIVES 117
9.6.2 SKIN ADHESIVES 117
9.6.3 THICKENERS 117
9.7 AGROCHEMICALS 118
9.8 FOOD & BEVERAGE 118
9.8.1 ALCOHOLIC 119
9.8.2 NON-ALCOHOLIC 119
9.9 MEMBRANES 119
9.9.1 WATER 120
9.9.2 HEMODIALYSIS 120
9.10 CERAMICS 120
9.11 HOME CARE 121
9.12 METAL QUENCHING 121
9.13 OTHERS 122
10 MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET, BY DISTRIBUTION CHANNEL 124
10.1 OVERVIEW 125
10.2 OFFLINE 126
10.3 ONLINE 127
11 MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET, BY REGION 128
11.1 MIDDLE EAST AND AFRICA 129
11.1.1 SOUTH AFRICA 138
11.1.2 UNITED ARAB EMIRATES 142
11.1.3 SAUDI ARABIA 146
11.1.4 EGYPT 150
11.1.5 ISRAEL 154
11.1.6 REST OF MIDDLE EAST AND AFRICA 158
12 MIDDLE EAST & AFRICA POLYVINYLPYRROLIDONE (PVP) MARKET: COMPANY LANDSCAPE 159
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 159
12.2 RECOGNITION 160
12.3 EVENT 160
12.4 JOINT VENTURE 160
12.5 CERTIFICATION 160
12.6 INVESTMENT 161
13 SWOT ANALYSIS 162
14 COMPANY PROFILES 163
14.1 BASF SE 163
14.1.1 COMPANY SNAPSHOT 163
14.1.2 REVENUE ANALYSIS 164
14.1.3 COMPANY SHARE ANALYSIS 164
14.1.4 PRODUCT PORTFOLIO 165
14.1.5 RECENT DEVELOPMENT 165
14.2 ASHLAND 166
14.2.1 COMPANY SNAPSHOT 166
14.2.2 REVENUE ANALYSIS 166
14.2.3 COMPANY SHARE ANALYSIS 167
14.2.4 PRODUCT PORTFOLIO 167
14.2.5 RECENT DVELOPMENT 168
14.3 NIPPON SHOKUBAI CO., LTD. 169
14.3.1 COMPANY SNAPSHOT 169
14.3.2 REVENUE ANALYSIS 169
14.3.3 COMPANY SHARE ANALYSIS 170
14.3.4 PRODUCT PORTFOLIO 170
14.3.5 RECENT DEVELOPMENT 170
14.4 BOAI NKY PHARMACEUTICALS LTD. 171
14.4.1 COMPANY SNAPSHOT 171
14.4.2 COMPANY SHARE ANALYSIS 171
14.4.3 PRODUCT PORTFOLIO 172
14.4.4 RECENT DEVELOPMENT 172
14.5 BALAJI AMINES 173
14.5.1 COMPANY SNAPSHOT 173
14.5.2 REVENUE ANALYSIS 173
14.5.3 COMPANY SHARE ANALYSIS 174
14.5.4 PRODUCT PORTFOLIO 174
14.5.5 RECENT DEVELOPMENT 174
14.6 ALFA AESAR, THERMO FISHER SCIENTIFIC 175
14.6.1 COMPANY SNAPSHOT 175
14.6.2 PRODUCT PORTFOLIO 175
14.6.3 RECENT DEVELOPMENT 175
14.7 HANGZHOU MOTTO SCIENCE & TECHNOLOGY CO., LTD. 176
14.7.1 COMPANY SNAPSHOT 176
14.7.2 PRODUCT PORTFOLIO 176
14.7.3 RECENT DEVELOPMENT 176
14.8 HUANGSHAN BONSUN PHARMACEUTICALS CO., LTD. 177
14.8.1 COMPANY SNAPSHOT 177
14.8.2 PRODUCT PORTFOLIO 177
14.8.3 RECENT DEVELOPMENT 177
14.9 JH NANHANG LIFE SCIENCES CO., LTD. 178
14.9.1 COMPANY SNAPSHOT 178
14.9.2 PRODUCT PORTFOLIO 178
14.9.3 RECENT DEVELOPMENT 178
14.10 MERCK KGAA 179
14.10.1 COMPANY SNAPSHOT 179
14.10.2 REVENUE ANALYSIS 179
14.10.3 PRODUCT PORTFOLIO 180
14.10.4 RECENT DEVELOPMENT 180
15 QUESTIONNAIRE 181
16 RELATED REPORTS 184

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.